Predicting brand share after LOE in chronic disease market using machine learning
{{output}}
Loss of Exclusivity (LOE) marks a turning point for brand-name drugs, triggering rapid share erosion as generics enter the market. Yet existing forecasting methods-often based on simple parametric decay curves-struggle with data scarcity, suffer from low predi... ...
